R
Market Data
$51.17+$10.49 (+25.79%)
RAPP · Last trade
Prev Close
$40.68
Range (29d)
$40.79 – $51.17
Recent Filings
- 1446.4 KBRapport Therapeutics, Inc.Aug 25, 4:29 PM ET·0001950047-26-008670
- 1445.7 KBRapport Therapeutics, Inc.Aug 24, 4:28 PM ET·0001950047-26-008594
- 1444.9 KBRapport Therapeutics, Inc.Aug 19, 4:38 PM ET·0001950047-26-008426
- SCHEDULE 13G/A15.4 KBRapport Therapeutics, Inc.Aug 14, 4:15 PM ET·0001193125-26-352285
- SCHEDULE 13G/A9.6 KBRapport Therapeutics, Inc.Aug 14, 2:05 PM ET·0001172661-26-003693
- SCHEDULE 13G/A7.7 KBRapport Therapeutics, Inc.Aug 12, 10:28 AM ET·0001562230-26-000114
- 10-Q9.8 MBRapport Therapeutics, Inc.Aug 5, 7:30 AM ET·0001193125-26-333862
- 8-K464.5 KBRapport Therapeutics, Inc.Aug 5, 7:17 AM ET·0001193125-26-333853
- 1445.3 KBRapport Therapeutics, Inc.Jun 29, 4:45 PM ET·0001958244-26-000411
- 8-K183.1 KBRapport Therapeutics, Inc.Jun 10, 4:12 PM ET·0001193125-26-265841
Insiders
10- ARCH Venture Fund XII, L.P.10% Owner
- Bredt DavidChief Scientific Officer
- Burow Kristina10% Owner
- Burrell Terry-AnnDirector
- Ceesay AbrahamDirector, Chief Executive Officer
- CRANDELL KEITH10% Owner
- Galer Bradley S.Chief Medical Officer
- Gault CherylChief Operating Officer
- GILLIS STEVEN10% Owner
- HEALY JAMESDirector
Tickers
Addresses
business
99 HIGH STREET SUITE 2100
BOSTON, MA, 02110
mailing
99 HIGH STREET SUITE 2100
BOSTON, MA, 02110
Former Names
- Rapport Therapeutics, Inc.2026-08-25